Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

DY, HQH, GFF, SAVW, MSLP - Market Watch From DrStockPick.com!

drstock-2-3

signup3m

MusclePharm Corporation (OTCBB:MSLP) has been invited to present at the upcoming HIV DART(NYSE:TM) 2010: Frontiers in Drug development for Antiretroviral Therapies Conference being held from December 7-10, 2010 in Los Cabos, Mexico.

This innovative conference, HIV DART(TM) 2010, will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community an increased understanding of the current and future challenges in therapeutics for HIV infection. This brings leaders in the research community together to advance the medical communities knowledge of the ongoing drug development processes in antiretroviral research.

At this year's HIV DART(TM) 2010 Conference, MusclePharm will present its results on the use of its product, Recon, in HIV patients. Early results show that Recon may help prevent the onset of wasting syndrome by facilitating the growth and maintenance of muscle mass in people living with HIV, which has been associated with antiretroviral drug resistance.

MusclePharm's President, Cory Gregory stated, "We started MusclePharm to enable people of all fitness levels to maintain and improve their general fitness through a daily nutritional supplement regimen. We are very pleased to have our work accepted by such a prestigious group of physicians and researchers focused on improving the lives of people with the HIV virus."

MusclePharm is a rapidly expanding healthy life-style company that develops and manufacturers a full line of NSF and scientifically approved nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. The Company's propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 US retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com.

***************************************************

http://pennyomega.com/img/savw.jpg

SavWatt USA, Inc. (OTC:SAVW), in cooperation with the City of Baltimore, will receive grant funds from the Maryland Energy Sector Grant. This million dollar grant will offer companies the ability to take LEED certification classes. LEED is an internationally recognized green building certified program. LEED certification important as many new construction and government projects are required to meet LEED standards. It is imperative for building owners, designers, construction firms and real estate developers to further develop their professional skills by obtaining LEED certification. SavWatt USA, Inc. has teamed up with the leaders in LEED training, Clean Edison, to offer this LEED AP certification at SavWatt's Baltimore, MD headquarters.

SavWatt USA, Inc. is pleased to announce that it has become an approved member of Energy Star. Having the Energy Star label will enhance the SavWatt USA Inc. brand to the public. Energy Star is a government backed program that helps businesses and individuals protect the environment through superior energy efficiency. SavWatt USA, Inc. has also been registered with the DOE (Department of Energy) and its Lighting Facts Label. This latest accomplishment along with the launch of its factory for LED tubes in January 2011 has made SavWatt USA, Inc. THE leader and brand in LED lighting.

SavWatt is leading the LED lighting revolution and setting the stage to obsolete the incandescent light bulb through the use of energy-efficient, environmentally friendly LED lighting. SavWatt is a market-leading innovator of LED lighting. SavWatt's product families include LED fixtures, bulbs, Street Lights and Parking Lights.

***************************************************

Griffon Corporation (NYSE:GFF) announced on November 22, 2010 that its Radar Systems Division has received a contract from The Boeing Company to supply APS-143C(NYSE:V)3 Multi-Mode Radar (NYSE:MMR) for India’s P-8i aircraft. The contract includes systems to support (8) P-8i Aft Radar installations integration and support services.“We are very pleased to have been selected for this important program,” said Kevin McSweeney, President of the Radar Systems Division. “We are looking forward to supporting Boeing on this program and to further serving the Indian Defence Force on future programs.”

Griffon Corporation, through its subsidiaries, operates as a manufacturing company. The company operates through three segments: Telephonics, Building Products, and Plastics. The Telephonics segment specializes in advanced electronic information and communication systems for defense, aerospace, civil, industrial, and commercial applications.

***************************************************

H&Q Healthcare Investors (NYSE:HQH) said that the record date for the stock distribution is November 22, 2010 and the payable date is December 30, 2010. The Fund traded ex-distribution on November 18, 2010. This stock distribution will automatically be paid in newly issued shares of the Fund unless otherwise instructed by the shareholder. The shares will be valued at the lower of the net asset value or market price on the pricing date, December 17, 2010. Fractional shares will generally be settled in cash, except for registered shareholders with book entry accounts at the transfer agent who will have whole and fractional shares added to their account.

H&Q Healthcare Investors is a close ended equity mutual fund launched and managed by Hambrecht & Quist Capital Management, LLC. The fund invests in the public equity markets across the globe. It invests in stocks of companies operating in the biotechnology, medical devices, and pharmaceuticals industries.

***************************************************

Dycom Industries Inc. (NYSE:DY) reported on November 23, 2010 that it has approximately $1.3 million of remaining authorization under its current share repurchase program. Since the repurchase program began, in February 2010, the Company has used approximately $38.7 million to acquire 4,007,002 shares of common stock. Accordingly, the Company announced that the Board of Directors has authorized an additional $20 million to purchase Dycom common stock under the Company’s existing share repurchase program. These purchases may be made over the next eighteen (18) months in open market (including through 10b5-1 plans) or private transactions at the discretion of management.

Dycom Industries, Inc. provides specialty contracting services in the United States and Canada. The company's services include engineering services, which comprise the design of service area concept boxes, terminals, buried and aerial drops, transmission and central office equipment, administration of feeder and distribution cable pairs, and fiber cable routing and design for telephone companies; and make-ready studies, strand mapping, field walk-out, computer-aided radio frequency design and drafting, and fiber cable routing and design for cable television multiple system operators.

***************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

drstbc

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (OTCPK:MSLP).

Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for SavWatt USA, Inc. (OTC:SAVW)